Amount Raised
$43 Million
Round Type
Series B
Description
Prilenia Therapeutics B.V., a clinical stage biotech company focused on developing novel treatments for neurodegenerative and neurodevelopmental disorders, today announced that it has raised $43M in an oversubscribed Series B financing round. The proceeds will be used to prepare for potential registration and commercialization of its lead drug candidate, pridopidine, for patients with Huntington’s Disease (HD) and Amyotrophic Lateral Sclerosis (ALS), as well as to accelerate timelines and expand the Company’s executive team and operations.
Quick answer
Prilenia raised $43 Million in a Series B round, dated November 3, 2021. Prilenia is based in Boston, Massachusetts, United States.
- How much did Prilenia raise?
- Prilenia raised $43 Million in a Series B round on November 3, 2021.
- What does Prilenia do?
- Prilenia is a clinical-stage biotech company focused on developing novel treatments for neurodegenerative and neurodevelopmental disorders.
- Where is Prilenia based and how big is it?
- Prilenia is based in Boston, Massachusetts, United States. Fundz records about 60 employees.
- Who are the decision-makers at Prilenia?
- Fundz holds 1 contact at Prilenia. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who to call at Prilenia, and when
A new round usually means Prilenia is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Prilenia raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Prilenia, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Prilenia. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Prilenia raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansPrilenia raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.